Home → Focus

FDA approves novel preventive treatment for migraine Print E-mail
Written by   
Thursday, 17 May 2018 00:00
The U.S. Food and Drug Administration today <5.17.18> approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, a molecule that is involved in migraine attacks.

"Aimovig provides patients with a novel option for reducing the number of days with migraine," said Eric Bastings, MD, Deputy Director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research.
Read the Press Release
Trump's 'American Patients First' Plan Announced Print E-mail
Written by FHI's Week in Review   
Monday, 14 May 2018 14:16

White House officials unveiled on Friday, 5.11.18 the broad contours of a plan to counteract rising prescription drug prices. The 44-page document, titled American Patients First, includes a three-page outline of the Trump administration's two-phase blueprint.

Read more in the current issue of Week in Review>>
Last Updated on Monday, 04 June 2018 17:00
The U.S. Department of Health and Human Services and the American Society of Nephrology to Launch Kidney Innovation Accelerator Print E-mail
Written by   
Tuesday, 01 May 2018 00:00

The U.S. Department of Health and Human Services (HHS) is pleased to announce a partnership with the  American Society of Nephrology to launch the Kidney Innovation Accelerator (KidneyX), KidneyX will engage a community of researchers, innovators, and investors to enable and accelerate the commercialization of therapies to benefit people with and at risk for kidney diseases through a series of prize competitions and coordination among federal agencies and the private sector.

More than 40 million Americans live with kidney diseases and 703,243 experience kidney failure. With an aging population and rising prevalence of diabetes and hypertension, more Americans need dialysis than ever before. Patients with chronic kidney disease continue to have limited treatment options and are particularly vulnerable in natural disasters when local dialysis centers are damaged or closed for more than a few days.

Read More
Physician Beats Burnout and Restores Quality of Life-with Scribes Print E-mail
Written by The Doctors Company   
Friday, 27 April 2018 15:04

Hans Haydon, MD, an internal medicine physician with Austin Regional Clinic, was distressed that time-consuming EHR documentation was driving down his clinic's patient numbers to levels that covered overhead but barely covered salaries. More importantly, it was driving up work hours and stress-part of the growing nationwide crisis of physician burnout.

"I'm no stranger to computer systems, as my father was an electrical engineer with IBM who helped develop the personal computer," he said. "But I never expected them to intrude directly into patient examination rooms ... I was considering early retirement because my quality of life as a physician had deteriorated."

Read More

Last Updated on Friday, 27 April 2018 15:12
How to Cope with Alert Fatigue Print E-mail
Written by Kang Hsu, MD | MEDITECH Blog   
Friday, 20 April 2018 16:43

As caregivers, we all fall victim to "alert fatigue," when the sheer number of alerts a clinician receives causes them to unknowingly miss important safety warnings. Ironically, all these alerts that are meant to improve patient safety can cause workers to become desensitized and potentially miss important warnings; from incessant smartphone buzzing, to tablet chimes or the blinking red indicators of your EHR.

Not everything is so dire, and we need to triage out the truly critical from the other serious notifications. In my opinion, the Agency for Healthcare Research and Quality (AHRQ) hits some great points in their very concise patient safety primer on the subject.

First, we need to increase alert specificity by getting rid of clinically inconsequential alerts. We should then conform alerts to individual patients and patient profiles. And finally, place all alerts on a tier system, according to severity. This could mean a color coded system, making higher-level alerts interruptive, or personalizing the warnings to the clinical user.

Last Updated on Friday, 20 April 2018 16:53
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 9 of 129

Website design, development, and hosting provided by